Kazakhstan has started production of Russia's Sputnik V vaccine - RDIF

Reuters, 21.12.2020

MOSCOW, Dec 21 (Reuters) - Kazakhstan has started production of Russia's Sputnik V vaccine against the coronavirus, Russia's RDIF sovereign wealth fund said on Monday.

Kazakhstan's Karaganda pharmaceutical complex produced a "validation batch" of the vaccine on Monday that will be sent for checks at Russia's Gamaleya Institute where Sputnik V was developed, RDIF said in a statement.